We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Spotlights Innovations and Trends in Clinical Diagnostics and Point-of-Care Testing

By LabMedica International staff writers
Posted on 21 Jul 2023
Print article
Image: The IMMULITE 2000 XPi immunoassay system (Photo courtesy of Siemens)
Image: The IMMULITE 2000 XPi immunoassay system (Photo courtesy of Siemens)

Siemens Healthineers (Erlangen, Germany) is highlighting its newest innovations and trends in clinical diagnostics and point-of-care testing at AACC 2023.

At the Siemens AACC 2023 booth, experts will provide a high-level overview of Atellica Integrated Automation. Powered for workflow and workforce efficiency, the company’s Atellica Solution delivers control and simplicity so labs can drive better outcomes. Experts will also demonstrate how the IMMULITE 2000 XPi immunoassay system can address common challenges faced by specialty laboratories. Providing multiple tests on a single, easy-to-use analyzer, the IMMULITE 2000 XPi immunoassay system makes it simple for labs to scale capabilities without disrupting regular day-to-day operations. It allows consolidation of routine and specialty testing, including allergy, on a single platform in labs with low to medium test volumes. Labs can incorporate specialty testing, including allergy, into routine workloads without interrupting the lab workflow in labs with medium to high test volumes.

Visitors to the Siemens booth at AACC 2023 also had the first view of the newly-launched Atellica CI Analyzer, a compact testing system designed to tackle lab challenges. The Atellica CI Analyzer1 for immunoassay and clinical chemistry testing is the newest addition to Siemens’ Atellica in vitro diagnostics portfolio. The Atellica CI Analyzer makes it possible for both standalone labs and satellite labs of wider health networks to have the same reagents, consumables, and intelligent software as the company's flagship Atellica Solution—now condensed into a 1.9 square meters footprint ideal for smaller laboratories. The Atellica CI Analyzer aims to address labor shortage pain points and drive revenue growth, fostering agility beyond standardization and clinical equivalence.

Siemens is also demonstrating how labs can leverage the power of open connectivity with POC informatics. With its POCcelerator Data Management System, labs can simplify their POCT workflows and dramatically reduce workload for their staff. All patient results, quality controls, operators, reagents, and device data can be collected and reviewed in a clear and structured format in order to comply with regulatory guidelines. In addition, Siemens is demonstrating the utility of its non-invasive tests such as the ELF Test in the NALFD/NASH patient referral pathway, alongside its advancements in VWD diagnostics for improved management of bleeding patients. Among its solutions for critical care testing, Siemens is showcasing its epoc Blood Analysis System that securely delivers critical testing results at the patient-side in less than one minute and connects the entire team, so it doesn’t matter if the laboratory staff and caregivers work in different parts of the hospital.

Related Links:
Siemens Healthineers

Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Auto-Chemistry Analyzer
CS-1200

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.